Drug News

Global Clinical Trial Supply and Logistics for Pharma Market Set for Strong Growth by 2033 Amid Digitization and Shift to Personalized Medicine

The global Clinical Trial Supply and Logistics for Pharma Market is poised for robust growth, with forecasted revenue exceeding US$13 billion in 2023 and continued growth expected through 2033. The evolving landscape in the pharmaceutical industry, marked by digitization, personalized medicine, and globalization, is reshaping the management and distribution of investigational products.

This report, added to ResearchAndMarkets’s offering, explores key trends, challenges, and opportunities, emphasizing the transformative role of technologies like 3D printing and the importance of embracing advancements for a more agile and patient-centric clinical trial supply chain.

Key Trends Shaping Clinical Trial Supply Logistics

1.        Digitization, Personalized Medicine, and Globalization:

•          The report underscores how trends towards digitization, personalized medicine, and globalization are influencing the approach to clinical trial supply logistics.

•          Regulatory compliance and patient-centricity remain priorities, but opportunities arise to leverage advanced technologies for agile and efficient supply chain operations.

2.        3D Printing and On-Demand Manufacturing:

•          The advent of 3D printing technology is identified as a transformative force in clinical trial supply logistics.

•          3D printing enables on-demand, localized production of medical devices, dosage forms, and personalized treatments, reducing transportation complexities and fostering a patient-centric approach.

Market Driving Factors:

•          Move towards decentralized/virtual trials.

•          Increasing possibilities for conducting clinical trials in Asia Pacific nations.

•          Growing clinical trials volume.

Market Restraining Factors:

•          Clinical trial and medical cold chain logistics.

•          Disruption in transportation due to man-made or natural events.

•          High financial costs associated with clinical trial supply logistics.

Market Opportunities:

•          Evolution of AI and machine learning with more data.

•          Acceptance of virtual trials and technology among patients and sites.

•          Market driven by big companies.

Segments Covered in the Report:

1.        Type:

•          CTS Manufacturing

•          CTS Logistics & Distribution

•          CT Supply Chain Management

•          CTS Packaging & Storage

2.        Phase:

•          Phase I

•          Phase II

•          Phase III

•          Phase IV

•          Post Launch

Leading Companies

The report includes profiles of leading companies operating in the Clinical Trial Supply and Logistics for Pharma Market, such as Almac Group, Bilcare, Biocair, Capsugel, Catalent, Inc., Eurofins Scientific, FedEx, ICON plc, Intertek Group plc, Kerry Logistics Network, Kuehne+Nagel, Marken, Mayne Pharma Group, Movianto, Parexel, PCI Pharma Services (PCI), Thermo Fisher Scientific, United Parcel Service, and Yourway.

The Clinical Trial Supply and Logistics for Pharma Market report offers a comprehensive analysis of the current and future landscape, providing stakeholders with valuable insights into market dynamics, growth opportunities, and challenges. Embracing technologies like 3D printing and adapting to the changing trends will be crucial for pharmaceutical companies seeking to optimize their clinical trial supply chains and deliver innovative therapies more efficiently.


Joan David-Leonhard

Joan David Leonhard is a recent Pharm.D graduate with a strong passion for the pharmaceutical industry and a particular interest in pharmaceutical media and communication. Her brief internship experience includes roles in pharmacy where she built strong patient-pharmacist relationships and a pharmaceutical media internship where she actively contributed to drug information articles, blog posts, social media engagement, and various media projects.
Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker